Identification of the cysteine-rich 61 (CYR61) gene variations in osteosarcoma patients | Zendy

Syed Rizwan Hussain | Zendy; Sabir Ali | Zendy; Ajai Singh | Zendy; Vineet Kumar | Zendy; Nazia Rizivi | Zendy; Manish Yadav | Zendy; Mohammad Kaleem Ahmad | Zendy; Vijay Kumar | Zendy; Abbas Ali Mahdi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Identification of the cysteine-rich 61 (CYR61) gene variations in osteosarcoma patients

Author(s) -

Syed Rizwan Hussain,

Sabir Ali,

Ajai Singh,

Vineet Kumar,

Nazia Rizivi,

Manish Yadav,

Mohammad Kaleem Ahmad,

Vijay Kumar,

Abbas Ali Mahdi

Publication year - 2017

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-1509-4

Subject(s) - exon , osteosarcoma , missense mutation , medicine , osteochondroma , cyr61 , gene , cancer research , malignancy , genetics , mutation , pathology , biology , ctgf , anatomy , growth factor , receptor

Osteosarcoma requires an angiogenesis process. CYR61 is one of the extracellular signaling molecules that promote angiogenesis, tumor growth, and the malignancy of osteosarcoma. In the present study, we investigate the CYR61 gene variations in osteosarcoma and their correlations with clinicopathological findings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research